Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
The Bridge
(Total Views: 226)
Posted On: 04/28/2022 1:34:30 PM
Post# of 128108
Posted By: Rusty
A new scientific study published 21st April 2022, has concluded that Covid-19 vaccination can elicit a distinct T cell-dominant immune-mediated hepatitis (liver inflammation) with a unique pathomechanism associated with vaccination-induced antigen-specific tissue-resident immunity requiring systemic immunosuppression.

The findings come just days after the World Health Organization issued a ‘global alert’ about a new form of severe hepatitis affecting children; and after the UK Government announced it was launching an urgent investigation after detecting higher than usual rates of liver inflammation (hepatitis) among children, after having ruled out the common viruses that cause the condition.

https://www.google.com/search?q=the+expose+me...p;ie=UTF-8

(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site